Inter Parfums Inc (IPAR) 29.64 $IPAR Inter Parfums

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 7:14 AM

Inter Parfums Inc (IPAR) 29.64 $IPAR

Inter Parfums misses 1Q profit forecasts
Automated Insights - Tue May 10, 3:41PM CDT
NEW YORK (AP) _ Inter Parfums Inc. (IPAR) on Tuesday reported first-quarter net income of $7.3 million.
IPAR: 29.64 (-1.04)

Inter Parfums, Inc. Reports 2016 First Quarter Results
BusinessWire - Tue May 10, 3:05PM CDT
Inter Parfums, Inc. (NASDAQ GS: IPAR) today reported results for the first quarter ended March 31, 2016.
IPAR: 29.64 (-1.04)

Inter Parfums Has Returned 25.3% Since SmarTrend Recommendation (IPAR)
Comtex SmarTrend(R) - Thu May 05, 1:23PM CDT
SmarTrend identified an Uptrend for Inter Parfums (NASDAQ:IPAR) on January 26th, 2016 at $24.80. In approximately 3 months, Inter Parfums has returned 25.32% as of today's recent price of $31.08.
IPAR: 29.64 (-1.04)

Inter Parfums, Inc. Schedules 2016 First Quarter Release for Tuesday, May 10th and Conference Call for Wednesday, May 11th
BusinessWire - Thu Apr 28, 10:27AM CDT
Inter Parfums, Inc. (NASDAQ GS: IPAR) today announced that it will issue financial results for the first quarter ended March 31, 2016 on Tuesday, May 10, 2016 after the close of the stock market.
IPAR: 29.64 (-1.04)

Inter Parfums, Inc. Reports 2016 First Quarter Sales
BusinessWire - Thu Apr 21, 3:05PM CDT
Inter Parfums, Inc. (NASDAQ GS:IPAR) today announced that for the three months ended March 31, 2016, net sales increased 2.1% to $111.5 million, from $109.2 million in the first quarter of 2015. At comparable foreign currency exchange rates, consolidated first quarter net sales increased 3.0% to $112.5 million as compared to the prior year period. For the current first quarter, the average U.S. dollar/euro exchange rate was 1.10 compared to 1.13 in the first quarter of 2015. Inter Parfums plans to issue results for the 2016 first quarter on or about May 10, 2016.
IPAR: 29.64 (-1.04)

Downgrade Alert for Inter Parfums (IPAR)
Comtex SmarTrend(R) - Wed Apr 20, 3:06AM CDT
Inter Parfums (NASDAQ:IPAR) was downgraded from Buy to Neutral at B. Riley today. The stock closed yesterday at $30.95 on volume of 123,000 shares, above average daily volume of 107,000. In the past 52 weeks, shares of Inter Parfums have traded between a low of $15.37 and a high of $38.94 and closed yesterday at $30.95, which is 101% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.1% while the 200-day MA has slid 0.2%.
IPAR: 29.64 (-1.04)

Inter Parfums Shares Up 23.9% Since SmarTrend's Buy Recommendation (IPAR)
Comtex SmarTrend(R) - Wed Apr 13, 12:30AM CDT
SmarTrend identified an Uptrend for Inter Parfums (NASDAQ:IPAR) on January 26th, 2016 at $24.80. In approximately 3 months, Inter Parfums has returned 23.91% as of today's recent price of $30.73.
IPAR: 29.64 (-1.04)

Inter Parfums Up 20.8% Since SmarTrend Uptrend Call (IPAR)
Comtex SmarTrend(R) - Mon Mar 28, 12:50PM CDT
SmarTrend identified an Uptrend for Inter Parfums (NASDAQ:IPAR) on January 26th, 2016 at $24.80. In approximately 2 months, Inter Parfums has returned 20.85% as of today's recent price of $29.97.
IPAR: 29.64 (-1.04)

Inter Parfums, Inc. Reports 2015 Fourth Quarter and Full Year Results
BusinessWire - Mon Mar 14, 6:45AM CDT
--Affirms 2016 Guidance
IPAR: 29.64 (-1.04)

Inter Parfums, Inc. Schedules 2015 Fourth Quarter Release and Conference Call for Monday, March 14th
BusinessWire - Fri Mar 04, 9:21AM CST
Inter Parfums, Inc. (NASDAQ GS: IPAR) today announced that it will issue financial results for the fourth quarter ended December 31, 2015 on Monday, March 14, 2016 before the stock market opens.
IPAR: 29.64 (-1.04)

Inter Parfums, Inc. Reports 2015 Fourth Quarter and Full Year Sales
BusinessWire - Tue Jan 26, 7:00AM CST
Inter Parfums, Inc. (NASDAQ GS:IPAR) today announced that for the three months ended December 31, 2015, net sales were $118.2 million, down 5.5% from $125.1 million for the final quarter of 2014. At comparable foreign currency exchange rates, consolidated fourth quarter net sales increased 1.0%. For the full year, net sales declined 6.2% to $468.4 million from 2014's $499.3 million. At comparable foreign currency exchange rates, consolidated 2015 net sales increased 1.5%. Inter Parfums plans to issue results for the 2015 fourth quarter and full year on or about March 14, 2016.
IPAR: 29.64 (-1.04)

Inter Parfums Down 13.2% Since SmarTrend Downtrend Call (IPAR)
Comtex SmarTrend(R) - Thu Jan 07, 3:25PM CST
SmarTrend identified a Downtrend for Inter Parfums (NASDAQ:IPAR) on December 11th, 2015 at $24.63. In approximately 4 weeks, Inter Parfums has returned 13.18% as of today's recent price of $21.38.
IPAR: 29.64 (-1.04)

Will Tyson (TSN) Q4 Earnings Lag on Weak Beef Segment?
Zacks Equity Research - Zacks Investment Research - Fri Nov 20, 9:20AM CST
Tyson Foods, Inc. (TSN) is set to report fourth-quarter fiscal 2015 results on Nov 23, before the opening bell. Last quarter, the company posted a 15.79% negative earnings surprise.
IPAR: 29.64 (-1.04), STZ: 153.40 (-0.70), TSN: 60.57 (-0.71), LNCE: 32.84 (-0.14)

Hillenbrand (HI) to Report Q4 Earnings: What to Expect?
Zacks Equity Research - Zacks Investment Research - Tue Nov 17, 9:20AM CST
Hillenbrand, Inc. (HI) is scheduled to report results for fourth-quarter fiscal 2015 (ended Sep 30, 2015) on Nov 18, after the market closes.
PRMW: 11.20 (+0.06), HI: 30.76 (-0.37), IPAR: 29.64 (-1.04), NYT: 11.85 (-0.19)

Inter Parfums, Inc. Provides Initial Guidance for 2016
BusinessWire - Tue Nov 17, 7:30AM CST
Inter Parfums, Inc. (NASDAQ GS:IPAR) today announced initial 2016 guidance, which calls for net sales in the range of $500 million to $510 million compared to the 2015 guidance range of $460 million to $470 million. Initial guidance for 2016 net income attributable to Inter Parfums, Inc. is in the range of $1.05 to $1.10 per diluted share compared to the 2015 guidance range of $0.95 to $1.00. Guidance assumes the dollar remains at current levels.
IPAR: 29.64 (-1.04), ANF: 18.75 (+0.11)

Will Lower Coffee Costs Aid J.M. Smucker (SJM) Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 3:45PM CST
The J. M. Smucker Company (SJM) is set to report fiscal second-quarter 2016 results before the opening bell on Nov 19.
IPAR: 29.64 (-1.04), STZ: 153.40 (-0.70), LNCE: 32.84 (-0.14), SJM: 144.24 (+1.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venue Two Eleven: Historic Charm Meets Modern Events

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

GELITA Showcases Collagen Innovations at SupplySide 2026

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Ama La Vida's New Coaching: More Than a Financial Plan

Breaking the Retirement Myth Retirement ain't just about sailing off into the sunset with a fat wallet. What happens when the honeymoon period of the "golden years" ends and you're left pacing the floorboards, unsure of what comes next? Enter Ama La Vida's fresh approach to retirement coaching, tackling the side of retirement that's rarely spoken about: identity,...

Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

New Chapter Recovery Garners Key Accreditations

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...